Micro Emerging Active

PFE TALZENNA Fase 3 Risultati

New narrative with limited coverage — still forming.

Punteggio
0,3
Velocità
▲ 0,0
Articoli
2
Fonti
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data Bullish
Mar 27, 2026
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study … Neutral

Cronologia

Prima apparizioneMar 27, 2026
Ultimo aggiornamentoMar 27, 2026